ClinConnect ClinConnect Logo
Search / Trial NCT04187131

An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

Launched by UNIVERSITY OF PITTSBURGH · Dec 2, 2019

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new tool that uses Augmented Reality (AR) and a brain activity measurement technique called electroencephalography (EEG) to help detect and treat a condition known as neglect in individuals who have had a stroke. Neglect can make it difficult for someone to pay attention to one side of their body or their surroundings, and this trial aims to see if this new technology is both feasible and acceptable for patients in rehabilitation.

To participate in this trial, individuals must be 18 years or older, have had an acute stroke, and be currently in inpatient rehabilitation. They should also show signs of neglect based on specific tests. Participants will be expected to engage with the AR tool during their rehabilitation process. It's important to note that those with certain conditions like dementia or Parkinson's disease, or who have metal in their heads that could interfere with the EEG, will not be eligible to join. Overall, the trial seeks to understand how well this innovative approach can help improve recovery for stroke patients dealing with neglect.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ages18 and older
  • acute stroke
  • admitted to inpatient rehabilitation
  • presence of neglect (Behavioral Inattention Test total score \<129, or scoring below pre-defined cutoff score in at least one of the six subtests)
  • more than 10/% missed targets on the Augmented Reality Screening Test
  • intact vibration (positive test on Vibration Sensation Test)
  • intact auditory function (positive test on Auditory Sensation Test)
  • English speaking
  • Exclusion Criteria:
  • inability to follow one-step directions at least 80% of the time
  • current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor
  • metal in the head that causes interference with the EEG system
  • self-report of previous positive photic stimulation test

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Murat Akcakaya, PhD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials